Ligand validation:8R96

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8R96_LFA_B_402	30%	100%	0.146	0.882	0.12	0.07	-	-	0	0	60%	0.6
8R96_LFA_E_403	29%	100%	0.111	0.829	0.08	0.08	-	-	0	0	65%	0.65
8R96_LFA_B_401	28%	99%	0.107	0.836	0.12	0.09	-	-	0	0	55%	0.55
8R96_LFA_A_401	23%	99%	0.138	0.841	0.12	0.08	-	-	0	0	55%	0.55
8R96_LFA_C_401	23%	98%	0.124	0.868	0.16	0.11	-	-	0	0	30%	0.3
8R96_LFA_E_401	22%	99%	0.125	0.823	0.12	0.08	-	-	0	0	55%	0.55
8R96_LFA_A_405	21%	100%	0.129	0.826	0.12	0.07	-	-	0	0	50%	0.5
8R96_LFA_A_404	20%	98%	0.108	0.828	0.14	0.11	-	-	0	0	35%	0.35
8R96_LFA_D_404	14%	100%	0.126	0.752	0.11	0.07	-	-	0	0	55%	0.55
8R96_LFA_A_406	13%	99%	0.119	0.777	0.13	0.09	-	-	0	0	35%	0.35
8R96_LFA_A_402	12%	99%	0.136	0.784	0.15	0.09	-	-	0	0	35%	0.35
8R96_LFA_C_403	9%	98%	0.105	0.722	0.16	0.11	-	-	0	0	30%	0.3
8R96_LFA_D_403	3%	99%	0.131	0.563	0.12	0.08	-	-	0	0	50%	0.5
8R96_LFA_D_405	2%	99%	0.22	0.565	0.13	0.09	-	-	1	0	40%	0.4
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	0.55
8R97_LFA_E_401	47%	100%	0.084	0.903	0.11	0.08	-	-	0	0	55%	0.55
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.